You are here

A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers

Last updated on February 21, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Bruxelles, , 1070 Belgium
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Pulmonary Disease, Lung Disease, Moxifloxacin
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy male and female subjects aged 18 to 55 years

- Informed consent document signed by the subject or a legally acceptable representative

- Subjects who are willing and able to comply with the scheduled visits, treatment
tests, laboratory tests, and other study procedures

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Evidence or history of clinically significant haematological, renal, endocrine,
pulmonary, gastrointestinal, cardiovascular, hepatic psychiatric, neurologic or
allergic disease or clinical findings at screening

- Conditions possibly affecting drug absorption

- 12-lead ECg demonstrating QTc > 450ms or any other clinically significant
abnormalities at screen

- Positive urine drug screen

- Hypersensitivity to moxifloxacin or PF00610335

- Unwilling or unable to comply with the lifestyle guidelines in the protocol Treatment
with an investigational drug within 3 months or 5 half lives (whichever is longer)
preceding the first dose of study medication

NCT01107054
Pfizer
Completed
A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Asthma, Chronic Obstructive Pulmonary Disease
NCT01033669
All Genders
18+
Years
Berlin,
Chronic Obstructive Pulmonary Disease
NCT00472264
All Genders
40+
Years
St. Louis, Missouri
Diabetes Mellitus, Chronic Obstructive Pulmonary Disease
NCT00138671
All Genders
30+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now